Trial
NCT03685591
PF-06952229 Treatment in Adult Patients With Advanced Solid Tumors
Phase ITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Pfizer
Collaborators
—
Condition
Breast Neoplasms
Intervention
PF-06952229
Why stopped
The decision to stop enrollment was due to strategic considerations and not due to any specific safety reasons or request from a regulatory authority.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2024-06-26